Newest American Academy of Arts and Sciences members | Stanford News – Stanford University News

Fifteen Stanford faculty members are among the 276 new members elected to the American Academy of Arts and Sciences, which honors exceptional scholars, leaders, artists and innovators engaged in advancing the public good.

From left to right starting from the top: Howard Y. Chang, Arogyaswami J. Paulraj, Michele Barry, Dan Jurafsky, Eva Silverstein, Caroline M. Hoxby, Jenny S. Martinez, Guadalupe Valdes, Anne Joseph OConnell, Kenneth F. Scheve, Thomas A. Rando, Paul V. Kiparsky, Thomas R. Clandinin, James Ferguson and Florencia Torche. (Image credit: Andrew Brodhead)

The new Stanford members to join the Class of 2020 are as follows:

Michele Barry, the Drs. Ben & A. Jess Shenson Professor, is the senior associate dean for global health and director of the Center for Innovation in Global Health in the Stanford School of Medicine. She is also a professor of medicine, a senior fellow at the Woods Institute and at the Freeman Spogli Institute. As the co-founder and co-director of the Yale/Stanford Johnson and Johnson Global Health Scholar Award, she has sent more than 1,000 physicians overseas to underserved areas to help strengthen health infrastructure in low-resource settings.

Howard Y. Chang, the Virginia and D.K. Ludwig Professor of Cancer Genomics and of Genetics, is a professor of dermatology and of genetics. He is also a Howard Hughes Medical Institute investigator. Changs research focuses on the role of epigenomics in the control of large groups of genes involved in cell cycle control, and on the study of long noncoding RNAs in biological development, cancer and aging.

Thomas R. Clandinin, the Shooter Family Professor, is a professor and chair of neurobiology. Clandinins research focuses on three central questions in neurobiology: how neuronal circuits assemble during development, how the functions of these circuits are maintained during adult life and how these circuits mediate the complex computations essential to animal behavior.

James Ferguson, the Susan S. and William H. Hindle Professor in the School of Humanities and Sciences, is a professor of anthropology. His research has focused on southern Africa. His recent work has explored the surprising creation and/or expansion both in southern Africa and across the global South of social welfare programs that target the poor and are anchored in schemes that directly transfer small amounts of cash to large numbers of low-income people.

Caroline M. Hoxby, the Scott and Donya Bommer Professor in the School of Humanities and Sciences, is a professor of economics and a senior fellow at the Hoover Institution and at the Stanford Institute for Economic Policy Research (SIEPR). Hoxby specializes in public economics, the economics of education and labor economics.

Dan Jurafsky, the Jackson Eli Reynolds Professor in Humanities, is a professor of linguistics and computer science. His research ranges across computational linguistics, including natural language understanding, human conversation, the relationship between human and machine processing and the application of natural language processing to the social and behavioral sciences. He also works on the linguistics of food and the linguistics of Chinese.

Paul V. Kiparsky, the Robert M. and Anne T. Bass Professor in the School of Humanities and Sciences, is interested in how words are structured, how the vocabulary of a language is organized, how word meaning relates to syntax, how languages change, and what all this tells us about the human mind. His current work focuses on the interface between phonology and morphology.

Jenny S. Martinez, the Richard E. Lang Professor of Law, is dean of Stanford Law School. Martinez is an expert on international law and constitutional law, including comparative constitutional law. She is the author of The Slave Trade and the Origins of International Human Rights Law (Oxford University Press, 2012). An experienced litigator, she has worked on cases involving international law and constitutional law issues.

Anne Joseph OConnell, the Adelbert H. Sweet Professor of Law, is a lawyer and political scientist whose research and teaching focuses on administrative law and the federal bureaucracy. OConnell has written on such topics as agency and judicial nominations, political appointees, bureaucratic organization (and reorganization), political changes in agency rulemaking, quasi-agencies and congressional oversight of agencies.

Arogyaswami J. Paulraj is a professor (research) of electrical engineering, emeritus, and is the inventor of MIMO wireless communications, a technology that enables improved wireless performance. MIMO is now incorporated into all new wireless systems. He also pioneered MIMO-OFDMA technology, which has become the core of 4G mobile systems.

Thomas A. Rando, professor of neurology and neurological sciences, is the director of the Glenn Center for the Biology of Aging at Stanford and of the Rehabilitation Research and Development Center of Excellence at the Veterans Affairs Palo Alto Health Care System. His research focuses on understanding the biological signals that activate stem cells in response to injury or other environmental cues, particularly in the context of aging.

Kenneth F. Scheve is a professor of political science and a senior fellow at FSI. His research interests are in the fields of international and comparative political economy and comparative political behavior, with particular interest in the behavioral foundations of the politics of economic policymaking. He is currently examining the role of social preferences in opinion formation about tax policy, trade policy and international environmental cooperation. His work also focuses on the political origins of changes in wealth inequality in the 19th and 20th centuries.

Eva Silverstein, professor of physics, explores basic problems in several areas of theoretical physics, including mechanisms for cosmic inflation, supersymmetry breaking, the stabilization of extra dimensions in string theory and the physics of black holes. She is also a principal investigator on the Simons Foundation Origins of the Universe program.

Florencia Torche is a professor of sociology. Her research interests are in social demography, stratification and education. A longer-term area of her research examines inequality dynamics, with a particular focus on educational attainment, assortative mating and the intergenerational transmission of wealth.

Guadalupe Valdes, the Bonnie Katz Tenenbaum Professor of Education at Stanford Graduate School of Education, is a founding partner of Understanding Language, an initiative at Stanford that focuses attention on the role of language in subject-area learning. Her research explores many of the issues of bilingualism relevant to teachers in training and the role of education in national policies on immigration.

The American Academy of Arts and Sciences serves the nation as a champion of scholarship, civil dialogue and useful knowledge. The academy is committed to interdisciplinary, nonpartisan research that provides pragmatic solutions for complex challenges.

More here:
Newest American Academy of Arts and Sciences members | Stanford News - Stanford University News

Global trade impact of the Coronavirus Animal Stem Cell Therapy Market Size Overview, Top Companies, Inventive Trends and Forecast to 2032 – Germany…

Companies in the Animal Stem Cell Therapy market are vying suggestive steps to tackle the challenges resulting from the COVID-19 (Coronavirus) pandemic. Exhaustive research about COVID-19 is providing present-day techniques and alternative methods to mitigate the impact on Coronavirus on the revenue of the Animal Stem Cell Therapy market.

The report on the Animal Stem Cell Therapy market provides a birds eye view of the current proceedings and advancements within the Animal Stem Cell Therapy landscape. Further, the report ponders over the various factors that are likely to impact the overall dynamics of the Animal Stem Cell Therapy market over the forecast period (20XX-20XX) including the current trends, business expansion opportunities and restraining factors amongst others.

As per the market report suggested by ResearchMoz.us, the global Animal Stem Cell Therapy market is expected to register a CAGR growth of ~XX% during the forecast period and attain a value of ~US$XX by the end of 20XX. Further, the report suggests that the growth of the Animal Stem Cell Therapy market is largely influenced by a range of factors including, emphasis on R&D innovations by market players, surging investments to increase product portfolio, and favorable regulatory policies among others.

Get Free Sample PDF (including COVID19 Impact Analysis, full TOC, Tables and Figures) of Market Report @ https://www.researchmoz.com/enquiry.php?type=S&repid=2638488&source=atm

Questions Related to the Animal Stem Cell Therapy Market Explained:

Competitive Landscape

The report provides critical insights related to the leading players operating in the Animal Stem Cell Therapy market. The revenue generated, market presence, product range, and financials of each company are enclosed in the report.

Segment by Type, the Animal Stem Cell Therapy market is segmented intoDogsHorsesOthers

Segment by Application, the Animal Stem Cell Therapy market is segmented intoVeterinary HospitalsResearch Organizations

Regional and Country-level AnalysisThe Animal Stem Cell Therapy market is analysed and market size information is provided by regions (countries).The key regions covered in the Animal Stem Cell Therapy market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, UAE, etc.The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.Competitive Landscape and Animal Stem Cell Therapy Market Share AnalysisAnimal Stem Cell Therapy market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Animal Stem Cell Therapy business, the date to enter into the Animal Stem Cell Therapy market, Animal Stem Cell Therapy product introduction, recent developments, etc.The major vendors covered:Medivet Biologics LLCVETSTEM BIOPHARMAJ-ARMU.S. Stem Cell, IncVetCell TherapeuticsCelavet Inc.Magellan Stem CellsKintaro Cells PowerAnimal Stem CareAnimal Cell TherapiesCell Therapy SciencesAnimacel

Do You Have Any Query Or Specific Requirement? Ask to Our Industry [emailprotected] https://www.researchmoz.com/enquiry.php?type=E&repid=2638488&source=atm

Regional Landscape

The regional landscape of the report provides resourceful insights related to the revenue share analysis of the Animal Stem Cell Therapy market in different regions. Further, the market attractiveness of each region provides players a clear understanding of the overall growth potential in each regional market.

End-User Analysis

The report provides an in-depth understanding of the various end-users of the Animal Stem Cell Therapy along with the market share, size, and revenue generated by each end-user.

Important Information that can be extracted from the Report:

You can Buy This Report from Here @ https://www.researchmoz.com/checkout?rep_id=2638488&licType=S&source=atm

Read the original post:
Global trade impact of the Coronavirus Animal Stem Cell Therapy Market Size Overview, Top Companies, Inventive Trends and Forecast to 2032 - Germany...

Coronavirus Doctors experiment with stem cell therapy on COVID-19 patients CBS News 9:39 AM – KTVQ Billings News

Doctors are hoping stem cell therapy could be a weapon in the fight against coronavirus. On Friday, regenerative medicine company Mesoblast announced a 300-person trial to determine whether stem cell treatments will work in COVID-19 patients suffering from severe lung inflammation.

One hospital in New York tried it as an experiment with 12 patients, 10 of whom were able to come off of ventilators.

"What we saw in the very first patient was that within four hours of getting the cells, a lot of her parameters started to get better," Dr. Karen Osman, who led the team at Mount Sinai, told CBS News' Adriana Diaz.

The doctor said she was encouraged by the results, though she was hesitant to link the stem cell procedure to her patients' recovery.

"We don't know" if the 10 people removed from ventilators would not have gotten had they not gotten the stem cells, she said. "And we would never dare to claim that it was related to the cells."

She explained that only a "randomized controlled trial" would be the only way "to make a true comparison."

Luis Naranjo, a 60-year-old COVID-19 survivor, was one of Mount Sinai's stem cell trial success stories. He told Diaz in Spanish that he was feeling "much better."

Naranjo's daughter, Paola, brought him to the emergency room, fearful she would not see her father again. Like so many families struck by the coronavirus, she was not allowed inside with him.

"I forgot to tell him that I love him," she said. "All I said was go inside, I hope you feel better."

During his hospital stay, Naranjo was unconscious and on a ventilator for 14 days.

Doctors proposed giving him stem cells from bone marrow in hopes it would suppress the severe lung inflammation caused by the virus.

Now, Naranjo credits the doctors who treated him for his survival. Though income from his family's jewelry business has been cut off and they found themselves falling behind on rent, Naranjo said he is focused primarily on his recovery and regaining the 25 pounds he lost at the hospital.

Although stem cell treatment, usually reserved for other diseases like rheumatoid arthritis, might end up being another step toward helping coronavirus patients recover, Dr. Osman was quick to say it would not be a "miracle treatment."

"The miracle treatment will be a vaccine," she said.

View post:
Coronavirus Doctors experiment with stem cell therapy on COVID-19 patients CBS News 9:39 AM - KTVQ Billings News

Call for ‘sofa life-savers’ as stem cell register takes a hit – Hereford Times

People have been urged to be a lifesaver from the sofa as a stem cell donor register has been adversely affected by the coronavirus crisis.

Charity DKMS said that the number of stem cell donor registrations is down by 50% compared with this time last year.

With operations and appointments being delayed, the need for donors will be much higher than usual in the months to come, it said.

The charity is encouraging people to register to become potential donors by sending swabs through the post.

People can sign up for a swab pack online, which will be posted out.

They then need to return the swabs in a pre-paid envelope which can be dropped to any local post box.

The family of a little girl with a rare blood cancer has backed the campaign.

Two-year-old Adeline Davidson, from Inverness, was diagnosed with myelodysplasia, a rare form of blood cancer, in February last year.

Her mother Steph Davidson, 26, said: We were so relieved when we heard that there was a match for Adeline, there were no words really this person who doesnt even know Adeline was giving her a second chance at life. It was the best news ever.

We were all ready for the transplant to start, but doctors took a throat swab from Adeline and found she had a common cold, so we had to wait a few days for that to clear up.

But in those few days the coronavirus situation completely blew up and we were told the transplant was no longer going to go ahead.

The transplant has been delayed for the foreseeable so we just have to wait and keep her healthy, because if she contracts any illness and has to be admitted to hospital, shes at high risk of infection.

She needs the transplant to live a normal life. We are a little fearful because of the delay and what this means for her future.

Were begging people to still register with DKMS if you can.

Jonathan Pearce, chief executive of DKMS UK, added: We are hugely concerned about the impact Covid-19 is having on those who rely on a blood stem cell donor.

While many stem cell transplants are still going ahead, the logistics around supporting blood stem cell donors to travel to hospital, and then arranging the transport of the stem cells to the transplant centre, have become much more challenging and complex.

There are also transplants that have been delayed, but once the pandemic is over we know there will be a backlog of patients in urgent need of an unrelated blood stem cell donor.

Sadly though, in some of those cases, theres a risk that the disease could progress further, and a transplant may no longer be possible once this is all over.

We still need many, many more potential blood stem cell donors to come forward, and we know from our clinicians that once the world is free of Covid-19, there will be even more transplants needed.

To find out more, visit https://www.dkms.org.uk/en/register-now

See the article here:
Call for 'sofa life-savers' as stem cell register takes a hit - Hereford Times

Insights on the Cell Expansion Industry in North America to 2027 – by Product, Cell Type, Application, End-user and Country – Yahoo Finance

Dublin, April 24, 2020 (GLOBE NEWSWIRE) -- The "North America Cell Expansion Market to 2027 - Regional Analysis and Forecasts by Product; Cell Type; Application; End User, and Country" report has been added to ResearchAndMarkets.com's offering.

The cell expansion market in North America is anticipated to reach USD 14,697.41 million by 2027 from USD 4,522.07 4 million in 2019; it is projected to grow at a CAGR of 15.9% during 2020-2027. The growth of the market is attributed to the increasing prevalence of cancer, rising number of new product launches, and increasing inclination of patients toward regenerative and personalized medicines. Also, growing R&D expenditure on cancer research is likely to have a positive impact on the growth of the market in the coming years. In addition, technological advancements in the pharmaceuticals industry and extensive developments in drug discovery are likely to stimulate the growth of cell expansion market in North America during the forecast period.

Cell expansion is the large-scale artificial production of daughter cells from a single cell, and the process is carried out to support the medical research. It plays a critical role in exploring a wider range of benefits and applications of fully differentiated stem cell cultures for their use in therapeutics, drug screening, or advanced research.

R&D is a significant part of a majority of pharmaceutical and biotech companies; they focus on R&D to come up with new molecules with the most significant medical and commercial potential for various therapeutic applications. The companies invest big amounts in these activities to deliver innovative, high-quality products to the market. Moreover, as per the report of Pharmaceutical Research and Manufacturers of America (PhRMA), the R&D expense of biopharmaceutical companies surged from US$ 49.6 billion in 2012 to US$ 58.8 billion in 2015.

Several government organizations are working on enhancing the detection methods and treatment procedures of cancer in the region. The National Cancer Institute (NCI) spends on various categories of the treatment, including specific cancer sites, cancer types, and cancer-related diseases, as well as types of NCI research mechanisms. The NCI allocated the funds of ~US$ 208.4 million for cell expansion research in 2017 from their total budget of US$ 5,636.4 million in that year for cancer research studies. Therefore, the growing R&D expenditure on cancer research by these companies is expected to provide them with opportunities for business expansion.

The North American cell expansion market has been segmented on the basis of cell type into human cells and animal cells. The human cells segment held a larger share of the market in 2018, and it is also projected to register a higher CAGR in it during the forecast period. Rise in research activities for the treatment of cancer is expected to offer considerable growth opportunities for the human cell expansion market players.

A few of the important secondary sources referred to for preparing this report on the cell expansion market are World Health Organization (WHO), Food and Drug Administration (FDA), Canadian Cancer Society, Centers for Disease Control and Prevention (CDC), and American Cancer Society.

Reasons to Buy:

Key Topics Covered:

1. Introduction1.1 Scope of the Study1.2 Report Guidance1.3 Market Segmentation1.3.1 North America Cell Expansion Market - By Product1.3.2 North America Cell Expansion Market - By Cell Type1.3.3 North America Cell Expansion Market - By Application1.3.4 North America Cell Expansion Market - By End User1.3.5 North America Cell Expansion Market - By Country

2. North America Cell Expansion Market- Key Takeaways

3. Research Methodology3.1 Coverage3.2 Secondary Research3.3 Primary Research

4. North America Cell Expansion Market - Market Landscape4.1 Overview4.2 PEST Analysis4.2.1 Cell Expansion Market - North America PEST Analysis4.3 Expert Opinion

5. North America Cell Expansion Market - Key Market Dynamics5.1 Key Market Drivers5.1.1 Patient shift towards regenerative medicines5.1.2 Increasing number of patients suffering with cancer5.2 Key Restraints5.2.1 Risk of contamination associated with the cell expansion process5.3 Key Market Opportunities5.3.1 Growing R&D Expenditure for Cancer Research5.4 Future Trend5.4.1 Extensive development in drug discovery5.5 Impact Analysis

6. Cell Expansion Market - North America Analysis6.1 North America Cell Expansion Market Revenue Forecasts and Analysis6.2 Positioning Of Key Players

7. North America Cell Expansion Market Analysis And Forecasts To 2027 - Product7.1 Overview7.2 North America Cell Expansion Market, By Product 2018 & 2027 (%)7.2.1 North America Cell Expansion Market Revenue and Forecasts to 2027, By Product (US$ Mn)7.2.1.1 North America Consumables Market Revenue and Forecasts to 2027, By Type (US$ Mn)7.2.1.1.1 North America Disposables Market Revenue and Forecasts to 2027, By Type (US$ Mn)7.2.1.2 North America Instruments Market Revenue and Forecasts to 2027, By Type (US$ Mn)7.3 Consumables7.3.1 Overview7.3.2 North America Consumables Market Revenue and Forecast to 2027 (US$ Mn)7.3.3 Reagents, Media & Serum7.3.3.1 Overview7.3.3.2 North America Reagents, Media & Serum Market Revenue and Forecast to 2027 (US$ Mn)7.3.4 Disposables7.3.4.1 Overview7.3.4.2 North America Disposables Market Revenue and Forecast to 2027 (US$ Mn)7.3.4.3 Culture Tissue Flasks7.3.4.3.1 Overview7.3.4.3.2 North America Culture Tissue Flasks Market Revenue and Forecast to 2027 (US$ Mn)7.3.4.4 Bioreactor Accessories7.3.4.4.1 Overview7.3.4.4.2 North America Bioreactor Accessories Market Revenue and Forecast to 2027 (US$ Mn)7.3.4.5 Other Disposables7.3.4.5.1 Overview7.3.4.5.2 North America Other Disposables Market Revenue and Forecast to 2027 (US$ Mn)7.4 Instruments7.4.1 Overview7.4.2 North America Instruments Market Revenue and Forecasts to 2027 (US$ Mn)7.4.3 Cell Expansion Supporting Equipment7.4.3.1 Overview7.4.3.2 North America Cell Expansion Supporting Equipment Market Revenue and Forecast to 2027 (US$ Mn)7.4.4 Bioreactors7.4.4.1 Overview7.4.4.2 North America Bioreactors Market Revenue and Forecast to 2027 (US$ Mn)7.4.5 Automated Cell Expansion Systems7.4.5.1 North America Automated Cell Expansion Systems Market Revenue and Forecast to 2027 (US$ Mn)

8. North America Cell Expansion Market Analysis And Forecasts To 2027 - Cell Type8.1 Overview8.2 North America Cell Expansion Market, By Cell Type 2018 & 2027 (%)8.2.1 North America Cell Expansion Market Revenue and Forecasts to 2027, By Cell Type (US$ Mn)8.3 Human Cells8.3.1 Overview8.3.2 North America Human Cells Market Revenue and Forecast to 2027 (US$ Mn)8.3.3 Adult Stem Cells8.3.3.1 Overview8.3.3.2 North America Adult Stem Cells Market Revenue and Forecast to 2027 (US$ Mn)8.3.4 Induced Pluripotent Stem Cells8.3.4.1 Overview8.3.4.2 North America Induced Pluripotent Stem Cells Market Revenue and Forecast to 2027 (US$ Mn)8.3.5 Embryonic Stem Cells8.3.5.1 Overview8.3.5.2 North America Embryonic Stem Cells Market Revenue and Forecast to 2027 (US$ Mn)8.3.6 Differentiated Cells8.3.6.1 Overview8.3.6.2 North America Differentiated Cells Market Revenue and Forecast to 2027 (US$ Mn)8.4 Animal Cells8.4.1 Overview8.4.2 North America Animal Cells Market Revenue and Forecast to 2027 (US$ Mn)

9. North America Cell Expansion Market Analysis- By Application9.1 Overview9.2 North America Cell Expansion Market, By Application 2018 & 2027 (%)9.3 Regenerative Medicine and Stem Cell Research9.4 Cancer and Cell-based Research9.5 Other Applications

10. North America Cell Expansion Market Analysis- By End User10.1 Overview10.2 North America Cell Expansion Market, By End User 2018 & 2027 (%)10.3 Biopharmaceutical And Biotechnology Companies10.4 Research Institutes10.5 Cell Banks10.6 Other End Users

11. Cell Expansion Market Revenue And Forecasts To 2027 - Geographical Analysis11.1 North America Cell Expansion Market, Revenue and Forecast to 202711.1.1 North America Cell Expansion Market, Revenue and Forecast to 2027 (US$ Mn)11.1.2 North America Cell Expansion Market, Revenue and Forecast to 2027, By Product (US$ Mn)11.1.2.1 North America Consumables Market, Revenue and Forecast to 2027, By Type (US$ Mn)11.1.2.1.1 North America Disposables Market, Revenue and Forecast to 2027, By Type (US$ Mn)11.1.2.2 North America Instruments Market, Revenue and Forecast to 2027, By Type (US$ Mn)11.1.3 North America Cell Expansion Market, Revenue and Forecast to 2027, By Cell Type (US$ Mn)11.1.3.1 North America Human Cell Market, Revenue and Forecast to 2027, By Type (US$ Mn)11.1.4 North America Cell Expansion Market, Revenue and Forecast to 2027, By Application (US$ Mn)11.1.5 North America Cell Expansion Market, Revenue and Forecast to 2027, By End User (US$ Mn)11.1.6 North America Cell Expansion Market, Revenue and Forecast to 2027, By Country (%)11.1.7 US11.1.8 Canada11.1.9 Mexico

12. North America Cell Expansion Market- Industry Landscape12.1 Overview12.2 Growth Strategies In The Cell Expansion Market, 2017-201912.3 Organic Growth Strategies12.3.1 Overview12.3.1.1 Recent Organic Developments By Players In The Cell Expansion Market12.4 Inorganic Growth Strategies12.4.1 Overview12.4.2 Recent Developments By Players In The Cell Expansion Market

13. Global Cell Expansion Market-Key Company Profiles13.1 BD13.1.1 Key Facts13.1.2 Business Description13.1.3 Financial Overview13.1.4 Product Portfolio13.1.5 SWOT Analysis13.1.6 Key Developments13.2 Merck KGaA13.3 Thermo Fisher Scientific, Inc.13.4 Terumo Corporation13.5 General Electric Company13.6 Corning Incorporated13.7 Miltenyi Biotec13.8 Danaher13.9 Lonza13.10 STEMCELL Technologies, Inc.

14. Appendix14.1 About the Publisher14.2 Glossary of Terms

For more information about this report visit https://www.researchandmarkets.com/r/gq37sj

Story continues

Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.

CONTACT: ResearchAndMarkets.comLaura Wood, Senior Press Managerpress@researchandmarkets.comFor E.S.T Office Hours Call 1-917-300-0470For U.S./CAN Toll Free Call 1-800-526-8630For GMT Office Hours Call +353-1-416-8900

See more here:
Insights on the Cell Expansion Industry in North America to 2027 - by Product, Cell Type, Application, End-user and Country - Yahoo Finance

UW-Madison: Academy adds new members from UW who ‘expand the boundaries of knowledge’ – Wisbusiness.com

MADISON Six University of Wisconsin-Madison faculty have been elected to the American Academy of Arts and Sciences.

Bioethicist R. Alta Charo, psychologist Seth Pollak, philosopher Steven Nadler, historian Louise Young, geographer Lisa Naughton and chemist Martin Zanni are among the 276 new members announced April 23. Election to the academy recognizes distinguished contributions by these scholars to their fields.

Former UW-Madison Provost Sarah Mangelsdorf was also elected to the academy this year. Mangelsdorf began her tenure as president of the University of Rochester in July 2019.

Charo is the Warren P. Knowles Professor of Law and Bioethics and an expert on law and policy related to research ethics, stem cell research and new medical technology. She has served as an adviser and expert to the federal government and multiple presidential administrations on ethical concerns in cutting-edge research. And she recently co-chaired a National Academy of Sciences panel to develop recommendations around human gene editing.

Pollak is the College of Letters & Science Distinguished Professor of Psychology. At UW-Madisons Waisman Center, he researches the link between childhood stress and well-being. Pollaks team has uncovered the lasting effects of negative experiences in childhood and seeks to use this knowledge to improve the social and emotional experiences of children and the adults they become.

Nadler is the William H. Hay II Professor and Evjue-Bascom Professor in Humanities and a philosopher specializing in early modern and Jewish philosophy. He has authored 13 books, including Rembrandts Jews, a Pulitzer Prize finalist, and the graphic book, co-authored with his son Ben Nadler, Heretics!: The Wondrous (and Dangerous) Beginnings of Modern Philosophy. Nadler currently serves as director of UW-Madisons Institute for Research in the Humanities.

Young is a professor of Japanese history. Her research has covered Japan in and around the Second World War, and she has authored two books on Japans culture before and during the war. Her current book projects include a history of the countrys transition from feudal systems to a modern class hierarchy and a reexamination of Japans role in creating the modern world from the mid-19th century onward.

Naughton is a professor of geography focused on the social and political consequences of biodiversity conservation. Her research has focused on protected areas, wildlife and land use conflicts in South America, and she has studied public attitudes toward wolf recovery in the Upper Midwest. She directed UW-Madisons Land Tenure Center from 2009 to 2013 and chaired the Nelson Institutes graduate program in Conservation Biology and Sustainable Development from 2007 to 2010.

Zanni is the V.W. Meloche-Bascom Professor of Chemistry. Using an innovative method known as two-dimensional spectroscopy, the Zanni lab studies topics in biophysics and the energy sciences. They have researched carbon nanotube energy transfer, solar cell charge transfer, and the ways in which protein aggregations lead to diseases such as Type 2 diabetes and cataracts. Zanni was elected a fellow of the American Physical Society in 2010.

The news that six colleagues are new members of the American Academy of Arts and Sciences is further evidence for a fact: Faculty at UW-Madison are extraordinary, says UW-Madison Provost Karl Scholz. We congratulate these six for this wonderful recognition and thank them, and all in the UW-Madison community, for relentless efforts to expand the boundaries of knowledge and understanding of the human condition.

The academy was formed in 1780 to honor exceptional individuals and engage them in advancing the public good. Members have included Benjamin Franklin, Alexander Hamilton, Margaret Mead and Martin Luther King Jr. This years new members include former Attorney General Eric Holder, author Ann Patchett and filmmaker Richard Linklater.

Read this article:
UW-Madison: Academy adds new members from UW who 'expand the boundaries of knowledge' - Wisbusiness.com

Potential Impact of COVID-19 on Induced Pluripotent Stem Cell Market Forecasted To Surpass The Value Of US$ XX Mn/Bn By 20582019-2019 – Jewish Life…

In 2018, the market size of Induced Pluripotent Stem Cell Market is million US$ and it will reach million US$ in 2025, growing at a CAGR of from 2018; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.

Persistence Market Research recently published a market study that sheds light on the growth prospects of the global Induced Pluripotent Stem Cell market during the forecast period (20XX-20XX). In addition, the report also includes a detailed analysis of the impact of the novel COVID-19 pandemic on the future prospects of the Induced Pluripotent Stem Cell market. The report provides a thorough evaluation of the latest trends, market drivers, opportunities, and challenges within the global Induced Pluripotent Stem Cell market to assist our clients arrive at beneficial business decisions.

Request Sample Report @ https://www.persistencemarketresearch.co/samples/17968

This study presents the Induced Pluripotent Stem Cell Market production, revenue, market share and growth rate for each key company, and also covers the breakdown data (production, consumption, revenue and market share) by regions, type and applications. Induced Pluripotent Stem Cell history breakdown data from 2014 to 2018, and forecast to 2025.

For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2018.

In global Induced Pluripotent Stem Cell market, the following companies are covered:

Company Profile

Request Report Methodology @ https://www.persistencemarketresearch.co/methodology/17968

The content of the study subjects, includes a total of 15 chapters:

Chapter 1, to describe Induced Pluripotent Stem Cell product scope, market overview, market opportunities, market driving force and market risks.

Chapter 2, to profile the top manufacturers of Induced Pluripotent Stem Cell, with price, sales, revenue and global market share of Induced Pluripotent Stem Cell in 2017 and 2018.

Chapter 3, the Induced Pluripotent Stem Cell competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.

Chapter 4, the Induced Pluripotent Stem Cell breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2014 to 2018.

Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2014 to 2018.

For any queries get in touch with Industry Expert @ https://www.persistencemarketresearch.co/ask-an-expert/17968

Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2014 to 2018.

Chapter 12, Induced Pluripotent Stem Cell market forecast, by regions, type and application, with sales and revenue, from 2018 to 2024.

Chapter 13, 14 and 15, to describe Induced Pluripotent Stem Cell sales channel, distributors, customers, research findings and conclusion, appendix and data source.

Read more here:
Potential Impact of COVID-19 on Induced Pluripotent Stem Cell Market Forecasted To Surpass The Value Of US$ XX Mn/Bn By 20582019-2019 - Jewish Life...

Global Cell Sorting Market 2020 Industry Analysis by Manufacturers, Type, Application, End-User and Forecast 2025 – Bandera County Courier

A new research study titled Global Cell Sorting Market Report 2020, Forecast to 2025 has been presented by Magnifier Research which offers a comprehensive analysis on the market. Users can benefit from this complete market research report with all the required useful information about this market. The report covers the important components related to the top sellers of the global Cell Sorting industry that influence the market. However, it inspects the primary formats changing the dynamics of the market. Likewise, it covers related current affairs, which will be influencing the market. What more, it simplifies the essential sections and also the sub-sections that represents the recent zone.

Key Components Covered in The Report:

The research document is a detailed study on the growth, investment opportunities, market statistics, growing competition analysis, major key players, industry facts, important figures, sales, prices, revenues, gross margins, market shares, business strategies, top regions, demand, and developments. The report further estimates the global Cell Sorting industry esteem chain, powerful business strategies, cost, structure, creation limit, conveyance, market range, and limits usage rate. The market provides basic information of market members and organizing profiling, contact data, item/benefit beds, income development, revenue generation, and gross deals. This study also provides sales, revenue, and market share for each player covered in this report for a period between 2015 and 2020.

DOWNLOAD FREE SAMPLE REPORT: https://www.magnifierresearch.com/report-detail/37752/request-sample

Following are the topmost key players covered in this global Cell Sorting market research report:- NanoCellect Biomedical, Innovative Biochips, Cesca Therapeutics, Fluidigm, LumaCyte, Union Biometrica, LevitasBio, RareCyte, Cytonome, Namocell, STEMCELL Technologies, Akadeum Life Sciences

Together with geography at the worldwide forecast to 2025 is just absolutely professional and thorough. Moreover, the research study lists the major regional countries, focusing on the remarkable regions:- North America (United States, Canada and Mexico), Europe (Germany, France, UK, Russia and Italy), Asia-Pacific (China, Japan, Korea, India and Southeast Asia), South America (Brazil, Argentina, Colombia etc.), Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa).

The market segment based on product type includes:- Cancer Cell, Immune Cells, Microbial Cell, Red Blood Cell/Platelet, Stem Cell, Other

Applications mentioned in this report:- Cell Research, Biomedical Diagnosis, Other

Furthermore, the global Cell Sorting market has been divided into types, applications, and regions. This data provides a detailed and accurate country-wise volume analysis and region-wise market size analysis of the global market. The report further includes market shares for 2015 and 2025, for each of the above-mentioned segments. It also highlights the export and import of the market. It also analyses the regional distribution of the industry in terms of development trends.

ACCESS FULL REPORT: https://www.magnifierresearch.com/report/global-cell-sorting-market-report-2020-forecast-to-37752.html

Points Covered In This Report:

Customization of the Report:This report can be customized to meet the clients requirements. Please connect with our sales team (sales@magnifierresearch.com), who will ensure that you get a report that suits your needs. You can also get in touch with our executives on +1-201-465-4211 to share your research requirements.

About Us

Magnifier Research is a leading market intelligence company that sells reports of top publishers in the technology industry. Our extensive research reports cover detailed market assessments that include major technological improvements in the industry. Magnifier Research also specializes in analyzing hi-tech systems and current processing systems in its expertise. We have a team of experts that compile precise research reports and actively advise top companies to improve their existing processes. Our experts have extensive experience in the topics that they cover. Magnifier Research provides you the full spectrum of services related to market research, and corroborate with the clients to increase the revenue stream, and address process gaps.

Contact UsMark StoneHead of Business DevelopmentPhone: +1-201-465-4211Email: sales@magnifierresearch.comWeb: http://www.magnifierresearch.com

Read more:
Global Cell Sorting Market 2020 Industry Analysis by Manufacturers, Type, Application, End-User and Forecast 2025 - Bandera County Courier

Synthetic Stem Cells Market research by Growth, Competitive methods and Forecast to 2026 – Latest Herald

Synthetic Stem Cells Market research report enhanced worldwide COVID19 Impact analysis on Market Size (Value, Production, Sales, Consumption, Revenue, and Growth Rate), Gross Margin, Industry Chain, Trends, Top Manufacturers, Development Trends, History and 6 Year Forecast. This Synthetic Stem Cells Market competitive landscapes provides details by topmost manufactures like (North Carolina State University, Zhengzhou University) with data such as Company Profiles, Trade Sales Volume, Gross, Cost, Industry Share By Type, Product Revenue , Specifications and Contact Information. Besides, Synthetic Stem Cells industry report helps to analyse competitive developments such as Joint Ventures, Strategic Alliances, Mergers and Acquisitions, New Product Developments, Research and Developments.

Get Free Sample PDF (including COVID19 Impact Analysis, full TOC, Tables and Figures)of Synthetic Stem Cells[emailprotected]https://www.researchmoz.us/enquiry.php?type=S&repid=2395700

Target Audience of the Synthetic Stem Cells Market in This Study: Key Consulting Companies & Advisors, Large, medium-sized, and small enterprises, Venture capitalists, Value-Added Resellers (VARs), Manufacturers, Third-party knowledge providers, Equipment Suppliers/ Buyers, Synthetic Stem Cells market Investors/Investment Bankers, Research Professionals, Emerging Companies, Service Providers.

Scope of Synthetic Stem Cells Market:Synthetic stem cells offer therapeutic benefits comparable to those from natural stem cells and could reduce some of the risks associated with stem cell therapies. Additionally, these cells have better preservation stability and the technology is generalizable to other types of stem cells.

On the basis of product type, this report displays the shipments, revenue (Million USD), price, and market share and growth rate of each type.

Cardiovascular Diseases Neurological Disorders Other Diseases

On the basis on the end users/applications,this report focuses on the status and outlook for major applications/end users, shipments, revenue (Million USD), price, and market share and growth rate foreach application.

Cancers Wounds and Injuries Musculoskeletal Disorders Blood disorders

Do You Have Any Query Or Specific Requirement? Ask to Our Industry[emailprotected]https://www.researchmoz.us/enquiry.php?type=E&repid=2395700

Geographically, the report includes the research on production, consumption, revenue, Synthetic Stem Cells market share and growth rate, and forecast (2020-2026) of the following regions:

Key Developments in the Synthetic Stem Cells Market:

To describe Synthetic Stem Cells Introduction, product type and application, market overview, market analysis by countries, Synthetic Stem Cells market Opportunities, Market Risk, Market Driving Force;

To analyze the manufacturers of Synthetic Stem Cells market , with Profile, Main Business, News, Sales, Price, Revenue and Market Share in 2016 and 2020;

To display the competitive situation among the top manufacturers in Global, with sales, revenue and Synthetic Stem Cells market share in 2016 and 2020;

To analyze the key countries by manufacturers, Type and Application, covering North America, Europe, Asia Pacific, Middle-East and South America, with sales, revenue and Synthetic Stem Cells market share by manufacturers, types and applications;

To analyze the Synthetic Stem Cells market Manufacturing Cost, Key Raw Materials and Manufacturing Process etc.

To analyze the Industrial Chain, Sourcing Strategy and Downstream End Users (buyers);

To describe Synthetic Stem Cells market sales Channel, Distributors, Traders, Dealers etc.

To describe Synthetic Stem Cells market Research Findings and Conclusion, Appendix, Methodology and Data Source.

Contact:

ResearchMozMr. Nachiket Ghumare,Tel: +1-518-621-2074USA-Canada Toll Free: 866-997-4948Email:[emailprotected]

Browse More Reports Visit @https://www.mytradeinsight.blogspot.com/

See original here:
Synthetic Stem Cells Market research by Growth, Competitive methods and Forecast to 2026 - Latest Herald

Stem Cell and Platelet Rich Plasma (PRP) Alopecia Therapies Market 2020 Industry Size, Growth, Revenue, Global Statistics and Forecast to 2026 – Cole…

Stem Cell and Platelet Rich Plasma (PRP) Alopecia Therapies Market Report covers the Size, share, Growth Industry preparation models, producing method, situation and business operations of this Market. Global Stem Cell and Platelet Rich Plasma (PRP) Alopecia Therapies Market industry report 2020-2026 report covers the most recent development establishing in the Market, development opportunities and situation.

Get Sample Copy @ https://www.orianresearch.com/request-sample/1479129

The report offers clearing sections of insights extracted by completely breaking down authentic and current improvements in the Stem Cell and Platelet Rich Plasma (PRP) Alopecia Therapies market. It additionally gives second to none cutting edge estimations to different essential elements including Stem Cell and Platelet Rich Plasma (PRP) Alopecia Therapies market size, share, net profit, sales, revenue, and growth rate.

The key players covered in this study

The key players covered in this studyOrange County Hair Restoration CenterHair Sciences Center of ColoradoAnderson Center for HairEvolution Hair Loss InstituteSavola Aesthetic Dermatology CenterVirginia Surgical CenterHair Transplant Institute of MiamiColorado Surgical Center & Hair Institute

Key Points Describing Various Key Points:-

Manufacturing Analysis The Stem Cell and Platelet Rich Plasma (PRP) Alopecia Therapies market gives a section featuring manufacturing process investigation approved by means of essential data gathered through Industry specialists and Key authorities of profiled organizations.

Stem Cell and Platelet Rich Plasma (PRP) Alopecia Therapies Market Competition Leading professionals have been investigated depending on their company profile, product database, capacity, product/service value, transactions, and cost/revenue.

Demand & Supply and Effectiveness Stem Cell and Platelet Rich Plasma (PRP) Alopecia Therapies report additionally provides distribution, Production, Consumption & EXIM (Export & Import).

Inquire more or share questions if any before the purchase on this report: https://www.orianresearch.com/enquiry-before-buying/1479129

The Stem Cell and Platelet Rich Plasma (PRP) Alopecia Therapies Market Report covers an analytical view with complete information on product representations, sales, and revenue by sector, including manufacturing cost breakdown, industrial chain, market effect factors. The Global Stem Cell and Platelet Rich Plasma (PRP) Alopecia Therapies market size will grow from USD in 2020 to USD by 2026, at estimated CAGR values.

The Stem Cell and Platelet Rich Plasma (PRP) Alopecia Therapies has been observing an impressive change in its size and value. The report introduces a detailed examination of the different segments and sub-sections of the market, including the product types, advancements, applications, industry verticals, and areas that are relied upon to command the Global Stem Cell and Platelet Rich Plasma (PRP) Alopecia Therapies market during the estimated forecast period.

Key Focused Regions in the Stem Cell and Platelet Rich Plasma (PRP) Alopecia Therapies market:

South America Stem Cell and Platelet Rich Plasma (PRP) Alopecia Therapies Market (Brazil, Argentina)

The Middle East & Africa Stem Cell and Platelet Rich Plasma (PRP) Alopecia Therapies Market (South Africa, Saudi Arabia)

Europe Stem Cell and Platelet Rich Plasma (PRP) Alopecia Therapies Market (Spain, U.K., Italy, Germany, Russia, France)

North America Stem Cell and Platelet Rich Plasma (PRP) Alopecia Therapies Market (U.S., Mexico, Canada)

Asia-Pacific Stem Cell and Platelet Rich Plasma (PRP) Alopecia Therapies Market (China, Japan, India, Southeast Asia)

Order a Copy of This Report: https://www.orianresearch.com/checkout/1479129

Table of Contents Describing Detail Research Report:

1 Stem Cell and Platelet Rich Plasma (PRP) Alopecia Therapies Market Overview

2 Global Stem Cell and Platelet Rich Plasma (PRP) Alopecia Therapies Market Competition by Manufacturers

3 Stem Cell and Platelet Rich Plasma (PRP) Alopecia Therapies Retrospective Market Scenario by Region

4 Global Stem Cell and Platelet Rich Plasma (PRP) Alopecia Therapies Historic Market Analysis by Type

5 Global Stem Cell and Platelet Rich Plasma (PRP) Alopecia Therapies Historic Market Analysis by Application

6 Company Profiles and Key Figures in Stem Cell and Platelet Rich Plasma (PRP) Alopecia Therapies Business

7 Stem Cell and Platelet Rich Plasma (PRP) Alopecia Therapies Manufacturing Cost Analysis

8 Marketing Channel, Distributors and Customers

9 Market Dynamics

10 Global Market Forecast

11 Research Finding and Conclusion

12 Methodology and Data Source

Customization Service of the Report:

Orian Research provides customization of reports as per your need. This report can be personalized to meet your requirements. Get in touch with our sales team, who will guarantee you to get a report that suits your necessities.

About Us:

Orian Research is one of the most comprehensive collections of Market intelligence reports on the World Wide Web. Our reports repository boasts of over 500000+ industry and country research reports from over 100 top publishers. We continuously update our repository so as to provide our clients easy access to the worlds most complete and current database of expert insights on global industries, companies, and products. We also specialize in custom research in situations where our syndicate research offerings do not meet the specific requirements of our esteemed clients.

Contact Us:

Ruwin Mendez

Vice President Global Sales & Partner Relations

Orian Research Consultants

US +1 (415) 830-3727

UK +44 020 8144-71-27

Email: [emailprotected]

Follow this link:
Stem Cell and Platelet Rich Plasma (PRP) Alopecia Therapies Market 2020 Industry Size, Growth, Revenue, Global Statistics and Forecast to 2026 - Cole...